Study Evaluating Etanercept in Moderate to Severe Asthma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The primary objective of the study is to assess the efficacy and safety of etanercept 25 mg given twice weekly in subjects with moderate to severe persistent asthma.
Epistemonikos ID: ed0b6859afd6b14953dc369b0938608604d93bc5
First added on: May 04, 2024